Novo Nordisk Reports Wegovy Weight Loss Success in Children
· Business · Wall Street Journal, Reuters
Novo Nordisk announced that its weight-loss drug Wegovy helped children lose weight during a clinical trial. The study focused on the efficacy of the injectable medication in a younger demographic. Results from the trial provide new data on the drug's impact on pediatric patients.
Why it matters
The study offers a potential new treatment pathway for pediatric obesity, a growing health concern that impacts long-term wellness outcomes for children.
Read the original report — Wall Street Journal
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.